These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Dose Comparison And Side Effect Profile Of Metformin Extended Release Versus Metformin Immediate Release. Hameed M; Khan K; Salman S; Mehmood N J Ayub Med Coll Abbottabad; 2017; 29(2):225-229. PubMed ID: 28718236 [TBL] [Abstract][Full Text] [Related]
8. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects. Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185 [TBL] [Abstract][Full Text] [Related]
9. Advantages of extended-release metformin in patients with type 2 diabetes mellitus. Jabbour S; Ziring B Postgrad Med; 2011 Jan; 123(1):15-23. PubMed ID: 21293080 [TBL] [Abstract][Full Text] [Related]
10. Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures. Neutel JM; Zhao C; Karyekar CS Diabetes Ther; 2013 Dec; 4(2):269-83. PubMed ID: 23881432 [TBL] [Abstract][Full Text] [Related]
11. Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review. Tan J; Wang Y; Liu S; Shi Q; Zhou X; Zhou Y; Yang X; Chen P; Li S Front Pharmacol; 2021; 12():669814. PubMed ID: 34079464 [No Abstract] [Full Text] [Related]
12. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult subjects. Boulton DW; Smith CH; Li L; Huang J; Tang A; LaCreta FP Clin Drug Investig; 2011; 31(9):619-30. PubMed ID: 21819160 [TBL] [Abstract][Full Text] [Related]
13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
14. Fixed-dose combination therapy in type 2 diabetes mellitus. Blonde L; San Juan ZT; Bolton P Endocr Pract; 2014 Dec; 20(12):1322-32. PubMed ID: 25370323 [TBL] [Abstract][Full Text] [Related]
15. Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey. Liu C; Tang S; An K; Zhang S; Zhou Y; Su N; Yang R; Liao X; An Z; Li S Front Pharmacol; 2021; 12():634561. PubMed ID: 34322016 [No Abstract] [Full Text] [Related]
16. Epidemiologic Surveillance of Glycemic Response to a Scored, Breakable, Extended Release, Fixed Dose Combination of Gliclazide and Metformin in Persons with Type 2 Diabetes. Kalra S; Das AK J Assoc Physicians India; 2017 Jun; 65(6):38-41. PubMed ID: 28782312 [TBL] [Abstract][Full Text] [Related]
17. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjects. Gummesson A; Li H; Gillen M; Xu J; Niazi M; Hirshberg B Clin Drug Investig; 2014 Nov; 34(11):763-72. PubMed ID: 25269885 [TBL] [Abstract][Full Text] [Related]
18. Overview of metformin: special focus on metformin extended release. Ali S; Fonseca V Expert Opin Pharmacother; 2012 Aug; 13(12):1797-805. PubMed ID: 22775758 [TBL] [Abstract][Full Text] [Related]
19. Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects. Khomitskaya Y; Tikhonova N; Gudkov K; Erofeeva S; Holmes V; Dayton B; Davies N; Boulton DW; Tang W Clin Ther; 2018 Apr; 40(4):550-561.e3. PubMed ID: 29548719 [TBL] [Abstract][Full Text] [Related]
20. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects. Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]